KYIP Capital completed the acquisition of a 36% stake in Chiron Group.

KYIP Capital, a provider of growth buy-out investment solutions, completed the acquisition of a 36% stake in Chiron Group, a healthcare services operator. Financial terms were not disclosed. “Chiron is a solid and scalable platform addressing a key healthcare need: strengthening regional diagnostics to improve prevention, early diagnosis, and access to care. This investment will support structured growth through both organic development and selective acquisitions,” Eugenio Conforti, KYIP Partner and Head of Investments at Impact Mission Fund.